Neurologic complications of bladder carcinoma: A review of 359 cases

Cancer

Volumn 97, Issue 9, 2003, Pages 2267-2272

  Anderson, Thomas S ^a   Regine, William F ^a   Kryscio, Richard ^a   Patchell, Roy A ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Bladder; Brain; Metastasis; Radiation; Spinal cord

Indexed keywords

ADULT; AGED; ARTICLE; BACKACHE; BLADDER CARCINOMA; BONE METASTASIS; BRAIN INFARCTION; BRAIN METASTASIS; CANCER STAGING; CARCINOMATOUS MENINGITIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; INFECTION; LEIOMYOSARCOMA; LUMBOSACRAL PLEXUS; MAJOR CLINICAL STUDY; MALE; MENINGEAL METASTASIS; METABOLIC ENCEPHALOPATHY; NEUROLOGICAL COMPLICATION; NORMOTENSIVE HYDROCEPHALUS; PELVIS PAIN SYNDROME; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SARCOMA; SEIZURE; SPINAL CORD COMPRESSION; SPINAL CORD METASTASIS; SQUAMOUS CELL CARCINOMA; SUBDURAL HEMATOMA; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NERVOUS SYSTEM DISEASES; SARCOMA; URINARY BLADDER NEOPLASMS;

EID: 0344088473     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11354     Document Type: Article

References (23)

1. Israel VK, Natale RB, Skinner DG. Bladder. Clin Oncol. 1995; 66:1419-1431.
2. Bears OH, Henson DE, Hutter RVP, Myers MH, editors. American Joint Committee on Cancer. Manual for staging of cancer, 3rd edition. Philadelphia: J.B. Lippincott, 1988.
3. Matthews DE, Farewell VT. Using and understanding medical statistics, 3rd revised edition. New York: Karger Publishing, 1996.
4. Patchell RA, Posner JB. Neurological complications of systemic cancer. Neurol Clin. 1985;3:729-750.
5. Cascino TL, Leavengood JM, Kemeny N, Posner JB. Brain metastases from colon cancer. J Neurooncol. 1983;1:203-209.
6. Galuzzi S, Payne PM. Brain metastases from primary bronchial carcinoma: a statistical study of 741 necropsies. Br J Cancer. 1956;10:408-414.
7. Newman S, Hansen H. Frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with brain bronchogenic carcinoma. Cancer. 1974;33:492-496.
8. Shamdas GJ, McLaren GD, Grimm T, Everson LK. Solitary cerebellar metastasis from transitional cell carcinoma of bladder. Urology. 1992;40:50-53.
9. Kishi K, Hirota T, Matsumoto K, Kakizoe T, Murase T, Fujita J. Carcinoma of the bladder: a clinical and pathological analysis of 87 autopsy cases. J Urol. 1981;125:36-39.
10. Wallmeroth A, Wagner U, Moch H, Gasser TC, Sauter G, Mihatsch MJ. Patterns of metastasis in muscle-invasive bladder cancer (pT2-4): an autopsy study on 367 patients. Urol Int. 1999;62:69-75.
11. Otto T, Bex A, Schmidt U, Raz A, Rubben H. Improved prognosis assessment for patients with bladder carcinoma. Am J Pathol. 1997;150:1919-1923.
12. Leadbetter WF, Colston JAC. Brain metastasis in carcinoma of the bladder. J Urol. 1935;38:267-277.
13. Clatterbuck RE, Sampath P, Olivi A. Transitional cell carcinoma presenting as a solitary brain lesion: a case report and review of the world literature. J Neurooncol. 1998;39:91-94.
14. Sulmoni A, Spiess J, Hauri D. Die matastasierung des blasenkarzinoms. Helv Chir Acta. 1973;40:464-465.
15. Eng C, Cunningham D, Quade BJ, Schwamm L, Kantoff PW, Skarin AT. Meningeal carcinomatosis from transitional cell carcinoma of the bladder. Cancer. 1993;72:553-557.
16. Mandell S, Wernz J, Morales P, Weinberg H, Steinfeld A. Carcinomatous meningitis from transitional cell carcinoma of bladder. Urology. 1985;25:520-521.
17. Behan WMH, Behan PO, Doyle D. Association of myasthenia gravis and polymyositis with neoplasia, infection and autoimmune disorders. Neuropathol (Berl). 1982;57:221-229.
18. Dominguez Molinero JF, Martinez Torres JL, Gomez Jimenez J, Palao Yago F, Vergara Alcaide E, Zuluaga Gomez A. Myasthenia gravis as paraneoplastic syndrome in small cell tumor of the bladder. Actas Urol Esp. 1997;21:268-271.
19. Greenlee JE, Dalmau J, Lyons T, Clawson S, Smith RH, Pirch HR. Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal. Ann Neurol. 1999;45:805-809.
20. Lowe BA, Mershon C, Mangalik A. Paraneoplastic neurological syndrome in transitional cell carcinoma of the bladder. J Urol. 1992;147:462-464.
21. Prestigiacomo CJ, Balmaceda C, Dalmau J. Anti-Ri-associated paraneoplastic opsoclonus-ataxia syndrome in a man with transitional cell carcinoma. Cancer. 2001;91:1423-1428.
22. Roelofs RI, Hrushesky W, Rogin J, Rosenberg L. Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology. 1984;34:934-938.
23. Graus F, Rodgers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine (Baltimore). 1985;64:16-35.